Investment Analysts’ Weekly Ratings Updates for Tenet Healthcare (THC)

Several brokerages have updated their recommendations and price targets on shares of Tenet Healthcare (NYSE: THC) in the last few weeks:

• 12/2/2025 – Tenet Healthcare had its price target raised by analysts at Guggenheim from $238.00 to $257.00. They now have a “buy” rating on the stock.
• 12/1/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/24/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/21/2025 – Tenet Healthcare had its price target raised by analysts at Barclays PLC from $229.00 to $240.00. They now have an “overweight” rating on the stock.
• 11/17/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – Tenet Healthcare had its price target raised by analysts at JPMorgan Chase & Co. from $200.00 to $230.00. They now have an “overweight” rating on the stock.
• 11/13/2025 – Tenet Healthcare had its price target raised by analysts at Wells Fargo & Company from $238.00 to $252.00. They now have an “overweight” rating on the stock.
• 11/11/2025 – Tenet Healthcare was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
• 11/3/2025 – Tenet Healthcare had its “buy” rating reaffirmed by analysts at Truist Financial Corporation. They now have a $240.00 price target on the stock, up previously from $225.00.
• 10/30/2025 – Tenet Healthcare had its price target raised by analysts at Royal Bank Of Canada from $230.00 to $252.00. They now have an “outperform” rating on the stock.
• 10/29/2025 – Tenet Healthcare was given a new $245.00 price target on by analysts at Raymond James Financial, Inc..
• 10/29/2025 – Tenet Healthcare had its price target raised by analysts at UBS Group AG from $238.00 to $260.00. They now have a “buy” rating on the stock.
• 10/29/2025 – Tenet Healthcare was given a new $232.00 price target on by analysts at Morgan Stanley. They now have an “overweight” rating on the stock.
• 10/29/2025 – Tenet Healthcare had its price target raised by analysts at Guggenheim from $221.00 to $238.00. They now have a “buy” rating on the stock.
• 10/29/2025 – Tenet Healthcare had its price target raised by analysts at Cantor Fitzgerald from $190.00 to $245.00. They now have an “overweight” rating on the stock.
• 10/17/2025 – Tenet Healthcare had its price target raised by analysts at Mizuho from $194.00 to $225.00. They now have an “outperform” rating on the stock.
• 10/14/2025 – Tenet Healthcare was given a new $225.00 price target on by analysts at Truist Financial Corporation.
• 10/14/2025 – Tenet Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $224.00 price target on the stock.
• 10/14/2025 – Tenet Healthcare is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $224.00 price target on the stock.
• 10/8/2025 – Tenet Healthcare had its price target raised by analysts at KeyCorp from $205.00 to $225.00. They now have an “overweight” rating on the stock.
• 10/8/2025 – Tenet Healthcare had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Tenet Healthcare had its price target raised by analysts at Wells Fargo & Company from $200.00 to $238.00. They now have an “overweight” rating on the stock.
• 10/7/2025 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $190.00 price target on the stock.
• 10/6/2025 – Tenet Healthcare was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.

Insider Buying and Selling

In other Tenet Healthcare news, insider R. Scott Ramsey sold 13,322 shares of Tenet Healthcare stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $205.11, for a total value of $2,732,475.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard W. Fisher sold 2,500 shares of the company’s stock in a transaction on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the transaction, the director directly owned 8,792 shares in the company, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 122,084 shares of company stock worth $23,843,196 over the last three months. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.